Search Results

Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.

• Authors : Ruperto N; Pediatric Rheumatology Collaborative Study Group (PRCSG) and the Paediatric Rheumatology International Trials Organisation (PRINTO)

Subjects: Abatacept*/Abatacept*/Abatacept*/adverse effects ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects ; Arthritis, Juvenile*/Arthritis, Juvenile*/Arthritis, Juvenile*/drug therapy

• Source: The Journal of rheumatology [J Rheumatol] 2021 Jul; Vol. 48 (7), pp. 1073-1081. Date of Electronic Publication: 2021 Jan 15.Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model:

Record details

Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial.

• Authors : Genovese MC; From Stanford University, Palo Alto, California; Arthritis Center of Nebraska, Lincoln, Nebraska

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy

• Source: The Journal of rheumatology [J Rheumatol] 2018 Aug; Vol. 45 (8), pp. 1085-1092. Date of Electronic Publication: 2018 Apr 15.Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model:

Record details

Cardiovascular (CV) Risk after Initiation of Abatacept versus TNF Inhibitors in Rheumatoid Arthritis Patients with and without Baseline CV Disease.

• Authors : Jin Y; From the Division of Pharmacoepidemiology and Pharmacoeconomics, and Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.

Subjects: Abatacept/Abatacept/Abatacept/*adverse effects ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*adverse effects ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy

• Source: The Journal of rheumatology [J Rheumatol] 2018 Aug; Vol. 45 (9), pp. 1240-1248. Date of Electronic Publication: 2018 May 15.Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model:

Record details

Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-α Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study.

• Authors : Harrold LR; From the University of Massachusetts Medical School, Worcester; Corrona LLC, Southborough, Massachusetts

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Anti-Citrullinated Protein Antibodies/Anti-Citrullinated Protein Antibodies/Anti-Citrullinated Protein Antibodies/*blood ; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*therapeutic use

• Source: The Journal of rheumatology [J Rheumatol] 2018 Jan; Vol. 45 (1), pp. 32-39. Date of Electronic Publication: 2017 Nov 01.Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model:

Record details

Longterm efficacy and safety of abatacept in patients with rheumatoid arthritis treated in routine clinical practice: effect of concomitant methotrexate after 24 weeks.

• Authors : Takahashi N; From the Department of Orthopedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, and Nagoya Medical Centre, and Nagoya Central Hospital, Nagoya; Department of Rheumatology, Toyohashi Municipal Hospital, Toyohashi

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy

• Source: The Journal of rheumatology [J Rheumatol] 2015 May; Vol. 42 (5), pp. 786-93. Date of Electronic Publication: 2015 Apr 01.Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model:

Record details

Differences in Predictive Factors for Sustained Clinical Remission with Abatacept Between Younger and Elderly Patients with Biologic-naive Rheumatoid Arthritis: Results from the ABROAD Study.

• Authors : Sekiguchi M; ABROAD Study Investigators

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use ; Arthritis, Rheumatoid/Arthritis, Rheumatoid/Arthritis, Rheumatoid/*drug therapy

• Source: The Journal of rheumatology [J Rheumatol] 2016 Nov; Vol. 43 (11), pp. 1974-1983. Date of Electronic Publication: 2016 Sep 01.Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model:

Record details

Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.

• Authors : Birolo C; From the Department of Pediatrics, Rheumatology Unit, University of Padua, Padua, Italy; Scientific Research Institute of Rheumatology RAMS, Moscow, Russian Federation

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use ; Arthritis, Juvenile/Arthritis, Juvenile/Arthritis, Juvenile/*drug therapy

• Source: The Journal of rheumatology [J Rheumatol] 2016 Nov; Vol. 43 (11), pp. 2068-2073. Date of Electronic Publication: 2016 Sep 15.Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model:

Record details

Abatacept in the treatment of severe, longstanding, and refractory uveitis associated with juvenile idiopathic arthritis.

• Authors : Tappeiner C; From the Department of Ophthalmology, Inselspital, University of Bern, Bern, Switzerland; Department of Ophthalmology, St. Franziskus Hospital, Münster, and University Duisburg-Essen, and Department of Ophthalmology, and Department of General Pediatrics, Centre for Pediatric and Adolescent Medicine, Interdisciplinary Uveitis Center, University of Heidelberg, Heidelberg, Germany

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Arthritis, Juvenile/Arthritis, Juvenile/Arthritis, Juvenile/*complications ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use

• Source: The Journal of rheumatology [J Rheumatol] 2015 Apr; Vol. 42 (4), pp. 706-11. Date of Electronic Publication: 2015 Feb 01.Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model:

Record details

Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials.

• Authors : Ruperto, Nicolino; Lovell, Daniel J.; Berman, Alberto

• Source: Journal of Rheumatology; Nov2023, Vol. 50 Issue 11, p1471-1480, 10p

Record details

Detailed Analysis of the Articular Domain in Patients with Primary Sjögren Syndrome.

• Authors : Moerman RV; From the Departments of Rheumatology and Clinical Immunology and Oral and Maxillofacial Surgery, University of Groningen, University Medical Center Groningen, the Netherlands.; R.V. Moerman, MD, Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen

Subjects: Abatacept/Abatacept/Abatacept/*therapeutic use ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*therapeutic use ; Rituximab/Rituximab/Rituximab/*therapeutic use

• Source: The Journal of rheumatology [J Rheumatol] 2017 Mar; Vol. 44 (3), pp. 292-296. Date of Electronic Publication: 2017 Jan 15.Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model:

Record details